Postmenopausal osteoporosis is a heterogeneous disorder characterized by a progressive loss of bone tissue that begins after menopause and leads to fracture within 15-20 years from the cessation of the ovarian function. Human leptin is a protein of 167 amino acids. It is manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is proportional to the total amount of fat in the body. Leptin's effects on bone are mediated via a central neuroendocrine signaling pathway, as well as directly on bone marrow stem cells to enhance their differentiation to osteoblasts and inhibit their differentiation to adipocytes. Aim of the Study: to detect the relation between serum leptin level, total lipid profile and bone mineral denisty in postmenopausal osteoporotic women. Subjects and Methods: The study was carried on 40 postmenopausal females. According to Dual Emergy X-ray absorptiometry (DEXA), the subjects were divided into group A, Tt-score <-2.5, group B, t-score <-1, leptin and lipid profile were measured for all subjects.
Introduction

World
Health Organization defined osteoporosis as having a Bone Mineral Density (BMD) that is 2.5 standard deviations below peak bone mineral density (1) . Osteoporosis affects over 200 million people worldwide including 40% of women aged 50 years and over, and 65% of women aged 70 years and over Kanis et al.. (2) Among the hormones involved in bone and mineral metabolism, leptin has become a subject of considerable interest. Leptin has been reported to have bone anabolic, antiresorptive, and anti-osteoclastogenic effects (3) . Leptin is a circulating neurohormone produced primarily by adipose tissue as the product of the obese (ob) gene (4) . In addition to white adipose tissue, it can also be produced by brown adipose tissue, placenta (syncytiotrophoblasts), ovaries, skeletal muscle, stomach (the lower part of the fundic glands), mammary epithelial cells, bone marrow and liver cells (5) (Margetic et al.). Leptin interacts with several types of receptors (Ob-Ra-Ob-Rf, or LepRa-LepRf) that in turn are encoded by a single gene, Ob-Rb is the only receptor isoform that can signal intracellularly via the JAK state and MAPK signal transduction pathways and is present in hypothalamic nuclei (6) . Leptin can also act directly on bone marrow stem cells to enhance their differentiation to osteoblasts and inhibit their differentiation to adipocytes (7) Shoshana et al. Postmenopausal Osteoporosis is something that most women are concerned about. The rate at which bone regeneration takes place slows down with age. The rate of regeneration decreases even more after a women goes through menopause. Therefore, women are more susceptible to osteoporosis after menopause (8) Total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL) cholesterol in the serum samples of the subjects were measured by immunoassay (ELISA).
Results
The age of the cases in our study was ranging between (50-70) years with mean ( 57.3+ 13.2) years, and the age of the controls ranging between ( 50-69 ) years with mean (61+15.2) years as shown in (table 1) . 
Discussion
Osteoporosis is a silent slowly progressive skeletal disease. It is characterized by low bone mass, deterioration of bone tissue and disruption of bone architecture, compromised bone strength and an increase in the risk of fracture. The risk for osteoporosis increases after menopause (11) Osteoporosis is a major public health problem in Egypt. Constructed Bone mineral density charts for Egyptian women showed that, in general, they have a lower bone mineral density compared to their western counterparts Sallam et al. (12) . In our study we aimed to detrmine the association between BMD and circulating serum leptin levels among postmenopausal osteoporotic women. We found that leptin level was significantly lower among osteoporotic females. So higher serum leptin level is associated with higher BMD This result is in agreement with Yamauchi et al. (13) who had conducted his study to One hundred and thirty-nine postmenopausal women (age 48-78 years, mean 62.5), who visited our outpatient clinic for the evaluation of osteoporosis, had reported that plasma leptin levels were positively correlated with BMD values, and multiple regression analysis revealed that this positive relationship was still observed with BMD values of the femoral neck and of the whole body, even after %fat and age were taken into account. Also Thomas et al. (14) who assessed the role of the candidate hormones, leptin, insulin, and estrogen in mediating fat mass effects on the skeleton in a sample of 137 premenopausal women (age range 21-54 years), 165 postmenopausal women (34-93 years), and 343 men (23-90 years) recruited from the general population, found that serum leptin correlated with BMD in women but not in men Another study done by Pasco et al. (15) found a significant positive association between the BMD and serum leptin in women. Cornish et al. (16) found that leptin given peripherally increased bone strength in mice and also increased proliferation of osteoblasts in vitro. On the contrary, Goulding et al. (17) have not found any relationship between BMD, bone turnover markers and leptin concentration in postmenopausal women. Also Iwamoto (18) found correlations between some skeletal sites and serum leptin, but not at the whole body, and the correlations with biochemical markers were weak. Aging is associated with changes in plasma levels of several hormones. There are several conflicting reports on leptin level changing during aging. In our study we found insignificant negative relation between age and leptin. This result is supported by Ostlund (19) who had found that circulating leptin is inversely related to age. Zhong et al. (20) found that Serum leptin concentration was significantly higher in postmenopausal than premenopausal women (p<0.001). In our study, positive correlation was found between leptin and BMI. Douchi et al. (21) had suggested that leptin may be a mediator between body fat and bone ,because serum leptin levels correlates positively with fat mass in healthy subjects. However, Pasco et al. (22) found that the positive correlation between leptin and bone mass was independent of body weight. Literature concerning relationships between HDL cholesterol levels and BMD is contradictory. Our study found that lipid profile is moderately related to BMD. The level of serum total cholesterol and low density lipoprotein cholesterol were inversely associated BMD of lumbar spines (L2-L4). Another study done by Aleksandar et al. (23) involved 300 women referred to densitometric examination as they belonged to the risk group of postmenopausal women, found that atherogenic lipoproteins negatively correlate with lumbar bone density. so Increase in values of cholesterol, LDL and triglyceride are connected with significant risk increase for the appearance of osteopenia or osteoporosis. Lumbar spine BMD was not associated with total cholesterol (TC), low density lipoprotein, cholesterol (LDL-C), and high density lipoprotein cholesterol (HLD-C) regardless of when the measurement was performed. In the current study, no significant correlation was found between TG and HDL and BMD lumbar spines (L2-L4). This result is consistent with the results of Zabaglia et al. 1998 (24) who had found no association between serum triglycerides and BMD in menopausal women. But, Adami et al. (25) had found that total body and hip BMD were positively related to serum triglycerides in women.
Conclusion
The current study has provided evidence that bone mineral density is influced by serum leptin level in postmenopausal women with statistically significant difference and positive correlation between serum leptin level and bone mineral density. As regard total lipid profile, in our study inverse correlation between serum leptin level and total serum cholesterol and low density lipoprotein cholesterol levels. Recommendations Serum leptin level measurement could be used as a simple and non invasive method for screening programs for osteoporosis in postmenopausal women.
